Summit Global Investments’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,000
Closed -$342K – 502
2022
Q1
$342K Hold
2,000
– – 0.03% 387
2021
Q4
$419K Buy
+2,000
New +$413K 0.03% 396
2021
Q2
– Sell
-2,942
Closed -$623K – 601
2021
Q1
$623K Buy
+2,942
New +$704K 0.04% 291

Other funds holding MED

Summit Global Investments's MED Position: Q2 2022 in Review

Summit Global Investments sold out of Medifast (MED) in Q2 2022, closing a stake of 2,000 shares — an estimated $342K sold.

Summit Global Investments first reported a position in MED in Q1 2021 and held it in 3 quarters. The position peaked at $623K in Q1 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

  • Summit Global Investments reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
  • Summit Global Investments sold 2,000 Medifast shares in Q2 2022, an estimated $342K.
  • Summit Global Investments first reported a position in Medifast in Q1 2021 and held it in 3 quarters.
  • Summit Global Investments's Medifast position peaked at $623K in Q1 2021.
  • 284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Summit Global Investments's 13F filing for Q2 2022, filed 23 Aug 2022.